Prescription drug · BLA
Admelog (Insulin lispro) NDC 70518-4275
Insulin lispro 100 U/mL · Injection, Solution · Subcutaneous · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-4275-0 | 70518427500 | 5 SYRINGE in 1 CARTON (70518-4275-0) / 3 mL in 1 SYRINGEMarketed from Feb 4, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Admelog
- Generic name (nonproprietary)
- insulin lispro
- Active ingredients
- Insulin lispro — 100 U/mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 209196
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical/Ingredient)
- Identifiers
- Product ID 70518-4275_5a947dc5-7059-82ab-e063-6394a90af352SPL ID 5a947dc5-7059-82ab-e063-6394a90af352SPL set ID 12ec9e3f-e2ac-43a1-b334-8b6538cf2bb0RxCUI 1652639, 1992171UNII GFX7QIS1II
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470518427500followed by a unit qualifier and the quantityPackage 70518-4275-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ADMELOG is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ADMELOG is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 70518-4275
- What is NDC 70518-4275?
- 70518-4275 is the product NDC for Admelog (insulin lispro), Insulin lispro 100 U/mL injection, solution, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Admelog (Insulin lispro).
- What is the active ingredient?
- Insulin lispro.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Admelog?
- 3 other product NDCs are listed under this name. See all Admelog NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Admelog products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0024-5926 | 00024-5926-05 |
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0024-5924 | 00024-5924-10 |
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5925 | 00024-5925-0000024-5925-05 |
Other NDCs under BLA 209196
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0024-5924 |
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5925 |
| Admeloginsulin lispro | Insulin lispro 100 U/mL | Injection, SolutionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0024-5926 |